Direct answer
Almost never a traditional bank. Lending against intellectual property is done by specialty finance companies, venture debt lenders, asset-based lenders with an intangibles practice, and a small number of funds built specifically around IP. What they have in common is that they underwrite the cash the IP produces or could produce, not the IP itself as an abstract asset.
If your patent, trademark, software, or content library generates licensing revenue, or is central to revenue you already earn, there is a real market for it. If it does not yet generate anything, the market is much narrower and the structures look more like equity than debt.
What kinds of lenders lend against intellectual property?
Four groups, and they want quite different things.
Specialty IP finance companies. The narrowest and most expert group. They lend against patent portfolios, trademark rights, music and film catalogues, and software. They have in-house or contracted valuation capability, which is the thing everyone else lacks, and they are comfortable taking a security interest in an intangible asset and enforcing it. They are also the smallest group by number.
Venture debt lenders. Common where the borrower is a funded technology company. The IP matters here mostly as downside protection rather than as the primary basis of the loan. The primary basis is usually the sponsor behind the company and the revenue trajectory. If you have institutional investors, this is often the shortest path.
Asset-based lenders with an intangibles practice. Traditional asset-based lending is built around receivables, inventory, and equipment. A subset of these lenders will include IP in the borrowing base, usually as a modest slice sitting alongside hard collateral rather than as the whole facility. If you have real receivables and inventory as well as IP, this is often the most economical route, because the IP improves a facility you could partly get anyway.
Royalty and revenue-interest funds. These are not always structured as loans. They buy a share of future licensing or royalty income. Worth knowing about because if your IP throws off a royalty stream, this can be cheaper than debt and does not sit on your balance sheet the same way.
Traditional banks are the group missing from that list, and that is not an accident.
Why do most banks say no to IP as collateral?
Three reasons, and none of them are about whether your IP is good.
They cannot value it on a standard form. A bank can look up what a used excavator is worth. There is no comparable table for a patent family. Valuing IP requires specialist work, and a lender who cannot value collateral cannot size a loan against it.
They are not confident they can sell it. Collateral is only worth what it fetches in a bad outcome. A liquidator can auction equipment in a week. Selling a patent portfolio or a trademark can take many months and depends on finding a buyer for whom it is specifically useful, which is a much smaller pool.
Regulatory capital treatment. Intangible collateral is generally treated less favourably than hard assets in bank capital rules, so an IP-secured loan can consume more capital than an equipment-secured loan of the same size. That makes it structurally less attractive for a bank regardless of the merits of your particular asset.
None of that means IP is bad collateral. It means IP is specialist collateral, and specialists are who lend against it.
What makes intellectual property financeable?
The pattern across every lender type above is the same. They are looking for IP that is registered, owned cleanly, and connected to money.
Registered. A recorded patent, a registered trademark, a registered copyright. Unregistered rights and trade secrets are real assets and can be commercially valuable, but they are much harder to take security over and much harder to enforce against.
Owned cleanly. The rights sit with the borrowing entity, with recorded chain of title, and are not already pledged elsewhere. Patent assignments are recorded publicly with the USPTO, so a lender will check, and unrecorded assignments from founders or former contractors are one of the most common reasons a file stalls.
Connected to money. Licensing income is the strongest case, because it is a cash flow the lender can see and, if necessary, redirect. Next strongest is IP that is central to revenue you already earn, where the lender can reason about what the business is worth without it. Weakest is IP with no revenue attached at all, where the file is really an equity conversation wearing a debt costume.
There is also a durability question. Patents expire. Trademarks renew indefinitely if you keep using and renewing them. Content and music catalogues have long tails. A lender is sizing against remaining useful life, so a patent with a few years left supports far less than one with well over a decade.
Lender types compared
| Specialty IP finance | Venture debt | ABL with intangibles | Royalty / revenue-interest funds | |
|---|---|---|---|---|
| Primary basis | The IP and the income it produces | The company, its sponsor and its trajectory | Your hard collateral, with IP added to the base | A specific income stream |
| Best for | Licensing revenue, catalogues, strong patent families | Funded technology companies | Businesses with receivables and inventory as well as IP | IP that already throws off royalties |
| Structure | Term loan or facility secured on the IP | Term loan, usually with warrants | Revolving borrowing base | Purchase of future income, often not debt |
| Valuation work | Extensive, and they do it in house | Light, IP is downside protection | Moderate, and usually outsourced | Focused on the income stream, not the asset |
| Speed | Slowest, valuation drives the timeline | Faster where a sponsor is involved | Moderate | Varies widely |
| What usually kills the file | Unclear ownership, or no income attached | No institutional backing | Not enough hard collateral to anchor it | Income stream too short or too concentrated |
What does an IP lender actually underwrite?
Not the IP. This is the single most useful thing to understand before you start, and it is where most first conversations go wrong.
A lender is underwriting the cash the IP produces, or the cash the business produces because of it. The intellectual property is what they take security over so they have a claim if things go wrong. It is not what they are betting on.
That distinction changes what you should bring. A thick technical description of your patent is not what moves the file. What moves the file is the licence agreements, the revenue those licences produce, the concentration of that revenue across licensees, how long the agreements run, and what happens to the business if the IP were removed from it. A file that answers those questions crisply gets taken seriously by all four lender types. A file that leads with how innovative the technology is usually does not.
Two consequences worth planning around. First, if your IP produces no income and is not load-bearing for income you already earn, expect the conversation to drift toward equity, and that is not the lender being difficult. Second, revenue concentration matters as much as revenue volume. One licensee producing everything is a materially weaker file than four producing the same total.
What paperwork do IP lenders ask for?
More than a conventional lender, and the extra items are all about proving you own what you say you own.
- Registration certificates for each asset, with current status and renewal dates
- Chain of title, including assignments from any founder, employee, or contractor who created the work
- Any existing security interests or liens against the IP
- All licence agreements, in full, not summaries
- Revenue attributable to the IP, ideally broken out rather than buried in a total
- Any existing third-party valuation, and who prepared it
- Standard business financials: bank statements, tax returns, and a current debt schedule
The two items that most often hold a file up are unrecorded assignments and licence agreements that were never fully executed. Both are fixable, and both are much cheaper to fix before you approach a lender than during underwriting. If you know one of them is an issue, deal with it first.
When IP-backed lending is the wrong answer
It is the wrong answer more often than it is the right one, and knowing that early saves months.
If the IP produces nothing and supports nothing. A registered patent with no licensees and no product behind it is an asset, but it is not a financeable one on a debt basis today. Grant funding, a strategic partner, or equity are the honest alternatives.
If you need money in two weeks. IP valuation is slow work. If the problem is a payroll or a receivables gap, a line of credit, a revenue advance, or invoice factoring will solve it long before an IP facility could close. Using the right product for a timing problem is not a compromise, it is the point.
If you already carry several short-term obligations. Layering an IP facility on top of stacked short-term debt does not fix the underlying problem and usually makes the next conversation harder. If daily or weekly payments are already squeezing the business, the honest first move is to look at what is actually driving the squeeze, not to add another obligation on top of it.
If the IP is genuinely core and you are not certain about the downside. Pledging IP the business could not operate without is a real decision, not a formality. It is often the right one. It should be a deliberate one.
Frequently asked questions
Related guides
Talk it through before you shop it around
The most expensive mistake in IP financing is approaching the wrong lender type first, spending six weeks in a process that was never going to fit, and arriving at the right one with a stale file.
Custom Capital Advisors is a brokerage. We are not a lender and we do not quote what any lender will do before your documents have been reviewed. What we can do before you send anything is tell you which of the four routes above your situation actually points at, and what to fix in your file first.
Talk to us about your IP